INTRODUCTION
Phosphorylation of structural and regulatory proteins is a major intracellular control mechanism in eukaryotes. The phosphorylation state of a protein is a dynamic process controlled by both protein kinases and protein phosphatases [1] . This review deals with those enzymes that dephosphorylate serine (Ser) and threonine (Thr) residues in proteins, whereas the tyrosine (Tyr) phosphatases and dual-specificity protein phosphatases will be discussed in a future issue of this journal. The structure of each Ser/Thr protein phosphatase will be discussed, followed by its regulation and probable physiological roles.
Based on biochemical parameters, Ser/Thr protein phosphatases were initially divided into two classes: type-I phosphatases (PP1) are inhibited by two heat-stable proteins, termed inhibitor-1 (1-1) and inhibitor-2 (1-2), and preferentially dephosphorylate the /3-subunit of phosphorylase kinase, whereas type-2 phosphatases are insensitive to the heat-stable inhibitors and preferentially dephosphorylate the x-subunit of phosphorylase kinase [1, 2] . Type-2 phosphatases can be further subdivided into spontaneously active (PP2A), Ca2l-dependent (PP2B) and Mg2+-dependent (PP2C) classes. The use of okadaic acid, a specific phosphatase inhibitor, further facilitated the discrimination between different classes [3] .
Although still widely in use, this classificatioh does not reflect the actual phylogenetic relationship between the different Ser/Thr protein phosphatases. Molecular cloning revealed that PP2A was in fact much more closely related to PPI than to PP2C. Moreover, in the past few years many novel protein phosphatases have been identified that do not fit into the above classification. Many of these protein phosphatases are closely related to the existing classes or are intermediates between classes. From a phylogenetic point of view, it would be more reasonable to group PP 1, PP2A and PP2B in a family I and PP2C in a family II. Recently a detailed comparison of the primary structures of 44 different protein Ser/Thr phosphatases, excluding PP2C, was carried out [4] . This revealed a common core structure that comprises two domains. The first domain is predicted to fold as a single /6 sheet flanked by a helices, whereas the second is predominantly helical [4] . This multiple alignment also shows that family I can be subdivided into PP1-like, PP2A-like and PP2B-like enzymes.
TOXIN INHIBITORS OF PROTEIN PHOSPHATASES
The discovery of many low-molecular-mass protein phosphatase inhibitors, which are able to penetrate living cells, has revolutionized the study of the function of protein phosphatases [5] . The best studied, and most widely used, is okadaic acid. This polyether fatty acid is produced by marine dinoflagellates and is the causative agent of diarrhoetic shellfish poisoning. Due to its polyether structure it is cell-permeable. It is a potent inhibitor of PP2A (Kj = 0.2 nM) and PPl (Ki = 20 nM), but is a much less efficient inhibitor of PP2B (Kj = 10 tM). In spite ofthese different sensitivities, okadaic acid cannot be easily used to discriminate between PPl and PP2A in vivo [3, 6] . Furthermore, okadaic acid does not rapidly penetrate cell membranes, but accumulates slowly, making it difficult to control the actual concentration of the compound in vivo. With cell-free extracts, however, the above-mentioned limitations do not exist, and okadaic acid is a valuable tool used to distinguish between different phosphatases acting upon a given substrate [3] .
Since the discovery of okadaic acid as a specific phosphatase inhibitor, a number of other phosphatase inhibitors (tautomycin, dinophysistoxin, calyculin, microcystin and nodularin) have also been described [5] . We wish to draw attention to yet another phosphatase inhibitor, cantharidin [7, 8] . This toxin is derived from blister beetles (a traditional Chinese medicine and aphrodisiac) and inhibits PP2A (IC50 = 0.16 p.M) more potently than PPI (IC50 = 1.7 jeM). Although less potent than okadaic acid, it has been successfully used recently to study the dephosphorylation of hsp26 in vivo [9] .
PROTEIN PHOSPHATASE 1 
Structure of PP1
Several recent reviews deal with the structure and function of PPI [1, [10] [11] [12] .The catalytic -subunit of PPI, termed PPlc, was originally isolated as a 33 kDa protein, but this turned out to be a proteolytic fragment of a 37 kDa protein. PPlc has been crystallized in the presence of the phosphatase inhibitor microcystin [13] , but to date no details of the atomic structure have been published.
Initially two isoforms of PPIc were cloned, termed ax and 3 [14] . PPlc, was later shown to be a cloning artefact [15] . In rat, cDNA cloning revealed the existence of at least four isoforms, termed a, yl, y2 and 8 [16] . Interestingly, the yl and y2 isoforms are produced by alternative splicing of the same primary transcript. The mouse homologues, derived from a brain library [17] , were termed dis2ml (for the yl isoform) and dis2m2 (for the a isoform). Later a homologue of the 8 isoform was found in a rabbit cDNA library and termed fl [18] .
PPlca expressed in insect cells, using a baculovirus vector, is mainly found as an insoluble protein. However, denaturation followed by rapid renaturation in the presence of Mn2+ results in reactivation of the enzyme [15] . Bacterially expressed PPlc (a. , ,8 and y isoforms) differs in some aspects (sensitivity to phosphatase 18 S. Wera and B. A. Hemmings inhibitors, binding to regulatory subunits, requirement for Mn2+ and specific activity) from native PPlc. The recombinant PPlc isoforms regain their native characteristics following incubation with 1-2 and subsequent phosphorylation of the latter by glycogen synthase kinase 3 (GSK3) [19] . A recent study of deletion mutants of PPlc [20] indicated that removal of the C-terminus of the protein (up to 33 residues) has no effect on the activity of the enzyme, nor on the binding of either okadaic acid or 1-2. A PPlc mutant was constructed in which residues 274-277 (-Gly-GluPhe-Asp-) of PPlc were replaced with residues 267-270 (-TyrArg-Cys-Gly-) of PP2A. Interestingly, this mutant displays a 10-fold increased sensitivity towards okadaic acid. One possibility to explain these results is that binding of okadaic acid and other toxins occurs at or near this site [21] . Alternatively, the effect of mutating residues 274-277 might cause a modest conformational change in the enzyme. This could also explain the 7-fold increased Km and 2-fold decreased Vmax of the mutant enzyme for its substrate phosphorylase.
The native structure of PPl is a 1: 1 complex between the catalytic and a number of different regulatory subunits [22] . The role of these regulatory subunits is to target the catalytic subunit towards specific subcellular locations (hence the name targeting subunits), and to increase activity towards particular substrates. Furthermore PPIc can associate with proteins that inhibit its activity. These inhibitors can also be considered as regulatory subunits. The holoenzymes are named according to their apparent subcellular location [10] . For example, the glycogenbound PP1 holoenzyme (PPIG) is a heterodimer of PPIc and a glycogen-binding subunit (G-subunit) [23] . The G-subunit anchors the phosphatase to glycogen and increases its activity towards the glycogen-bound substrates: glycogen synthase and glycogen phosphorylase [24] . These substrates are activated and inactivated respectively by dephosphorylation. The G-subunit was purified from skeletal muscle [23] . Molecular cloning revealed a molecular mass of 124 kDa [25] . The Saccharomyces cerevisiae homologue of the G-subunit (encoded by the GAC] gene) has also been identified [26] .
The PP 1 holoenzyme isolated from muscle sarcoplasmic reticulum has the same subunit composition as PP 1G. It therefore appears that the G-subunit can target PPlc to either glycogen or the sarcoplasmic reticulum [27] . The G-subunit has a region of 32 hydrophobic residues at its C-terminus, which is probably responsible for the interaction of the G-subunit with membranes [25] . Sarcoplasmic reticulum-located PP1G is the major phosphatase that acts upon phospholamban [28] , a protein involved in Ca2+ uptake into the cardiac SR and in the regulation of the rate of cardiac muscle relaxation. Highly purified preparations of the glycogen-bound protein phosphatase from rat liver (PPlG,) were shown to contain PP1c and polypeptides of 54 kDa and 161 kDa [29] . Based on immunological data, activity measurements and partial peptide sequences, the 54 kDa polypeptide is identical or highly related to liver amylase, and most likely is not essential for the regulatory properties of the enzyme [10, 29] . The structure of the 161 kDa component has not yet been described, but could be functionally related to the skeletal muscle G-subunit (see below).
The PPI bound to the myosin fraction in smooth muscle was purified as a trimer consisting of PP1c and polypeptides of 130 kDa and 20 kDa. The latter subunits are responsible for enhanced activity towards heavy meromyosin or isolated myosin light chains [30] . The 58 kDa component found in some preparations of myosin-bound PPI from smooth muscle seems to be a proteolytic derivative of the 130 kDa component [31] . The myosin-bound form of PPI in skeletal muscle (PPIM) was subunit that increased dephosphorylation of the myosin light chain, present in heavy meromyosin [32] . High levels of PP1 activity are also present in the nuclei of eukaryotic cells [33] . Strikingly, upon subnuclear fractionation more than 9000 of this phosphatase activity is found in the chromatin fraction [34] , and immunofluorescence reveals that PP1 co-localizes with individual chromosomes during mitosis [35] . Part of the nuclear PPI is present in a latent form (termed PP1N9), and is composed of PPIc complexed to an inhibitory (NIPP-1) polypeptide [36] . Two highly related forms of NIPP-1 (termed a and b) have been purified from bovine thymus [34] and migrate on SDS/PAGE as 18 kDa and 16 kDa proteins respectively.
A cytosolic form of PP1, termed PPIS, is composed of PPlc complexed to 1-2 (also termed the modulator subunit). Upon purification of PP I S, the enzyme gradually converts to an inactive conformation (reviewed in [10, 11] [19] . It is possible, however, to prevent the inactivation of PPIS by the inclusion of low concentrations of fluoride in the isolation buffers during the purification [37] . Under these conditions PP1S can be isolated as an active phosphatase, with no evidence found for a pool of inactive enzyme. These recent observations argue strongly against a role for 1-2 as a chaperone in vivo.
PPlcy2, an isoform of PPlc that is particularly enriched in testis, was purified as a complex with proteins of 78 kDa and 55 kDa. Partial amino acid sequence data suggest that the 78 kDa subunit is identical to the 78 kDa glucose-regulated protein, a member of the 70 kDa heat-shock protein family [38] . The physiological significance of the association of PPlcy2 with these proteins is unclear at the moment.
Using the yeast two-hybrid system, it was shown that the retinoblastoma gene product binds to PPlca2, a variant of PPIc with an N-terminal 11-amino-acid insert. PP1cca2 binds preferentially to the hypophosphorylated forms of retinoblastoma protein. The association seems to occur during early GI. The authors suggest that binding of PP1 to retinoblastoma keeps the latter in the hypophosphorylated state [39] .
Heat-stable inhibitors of PP1 1-1 is a 18.7 kDa protein which becomes inhibitory to PPI after phosphorylation on Thr-35 by cyclic AMP (cAMP)-dependent protein kinase (cAMP-PK). Phosphorylation of I-1 occurs in vivo in skeletal muscle after adrenaline injection and also in rabbit liver after glucagon administration (reviewed in [1, 10] Figure 1 Possible mechanism for the control of nuclear PP1
Part of the nuclear PP1 activity is present as a latent enzyme consisting of PPlc complexed with the inhibitor NIPP-1. Phosphorylation of NIPP-1 by cAMP-PK (PKA) relieves the inhibition of PPlc [34, 36] and leads to dephosphorylation of nuclear proteins (X). PP2A reverses the effect. Inhibition of nuclear PP2A with okadaic acid (OA) is expected to activate PP1.
but it is also found in renal tubule cells, adrenal medulla, pineal gland, choroid plexus and brown adipose tissue.
1-2 (or modulator subunit) is a 22.8 kDa protein without sequence identity to 1-1. The inhibition of PPlc bv 1-2 is clearly different from the above described inactivation, since it requires much higher 1-2 concentrations, and is reversible upon 1-2 destruction [10] . 1-2 is encoded by two transcripts that differ in the 3' untranslated region, proAably due to the use of alternative polyadenylation signals [40] .
Regulation of PP1
The activity of PPlc in the different holoenzyme complexes is primarily mediated through the regulatory subunits [22] .
Regulation of the glycogen-bound PP1 from skeletal muscle Phosphorylation of the G-subunit by cAMP-PK at site-2 results in the release of PPlc [41] . At physiological salt concentrations, free catalytic subunit is about 5-fold less active in dephosphorylating glycogen phosphorylase and glycogen synthase [24] and will presumably be further inhibited by 1-1. Phosphorylation of site-2 occurs in vivo in response to adrenaline (acting via cAMP) and the resulting dissociation of PP1G contributes significantly to the inactivation of glycogen synthase [42, 43] . Conversely, dephosphorylation of site-2 in vitro is catalysed by PP2A, PP2B and PP2C [41] . Dephosphorylation of site-2 by PP2B, after an intracellular Ca2l rise in vivo, would also lead to reactivation of PP1G in response to Ca2+-mobilizing stimuli. Whether such a mechanism operates in vivo remains to be established.
Insulin, acting through the mitogen-activated protein (MAP) kinase pathway, stimulates the activity of an insulin-stimulated protein kinase-l or MAPKAP kinase-l 1 [44] , which is identical to rskro-2 and S6 kinase 1I [45] . This kinase phosphorylates site-l on the G-subunit, which does not lead to dissociation of PP1G, but to a 3-fold increase in its glycogen synthase phosphatase activity [44] . This mechanism explains the stimulatory effect of insulin on glycogen synthesis in skeletal muscle. G-subunit phosphorylated at site-I is an excellent substrate for GSK3, but the physiological consequences of this phosphorylation are unclear at present [46, 47] . GSK3 also phosphorylates and inactivates glycogen synthase directly. Furthermore, GSK3 is inactivated through MAPKAP-kinase-l-mediated phosphorylation [48, 49] . Thus insulin administration not only activates the synthase phosphatase (PPIG), but also inactivates an important synthase kinase (GSK3).
Regulation of the glycogen-bound protein phosphatase from liver
The glycogen-bound PPI from liver (PPIG) is regulated differently from its muscle counterpart. Liver glycogen synthase phosphatase activity is strongly inhibited by phosphorylase a through an allosteric mechanism [50, 51] . This mechanism most likely replaces the direct regulation through G-subunit phosphorylation which is observed in skeletal muscle. Agents that promote phosphorylation (activation) of liver phosphorylase a lead to inhibition of the synthase phosphatase activity of PPI G1, and thus stimulate glycogenolysis while at the same time inhibiting glycogen synthesis.
Regulation of nuclear PP1 Latent PPlN N can be activated in vitro through phosphorylation of NIPP-1 by cAMP-PK or casein kinase 11 [36, 52] . PP2A can reverse this activation. It remains to be determined whether PP2A exerts the same effect in vivo but, if so, PP2A could control PP1 activity in the nucleus, as shown in Figure 1 . This might explain why inhibition ofPP2A (through okadaic acid treatment) leads to dephosphorylation of certain nuclear phosphoproteins [53] , although an indirect effect of okadaic acid on protein kinases cannot be excluded. In much the same way, the activation of PPIN, by cAMP-PK might explain why cAMP induces dephosphorylation of certain proteins [54] . Further work is necessary to validate these hypothetical regulatory mechanisms. The regulation of nuclear phosphatases is poorly understood at the moment and could be a fruitful avenue of research in the future.
Physiological role of PP1 From the previous discussion, it is clear that PPI is involved in many different cellular processes, as diverse as glycogen metabolism, calcium transport, muscle contraction, protein synthesis and intracellular transport (reviewed in [1, 10, 12] ). In some cellular processes the substrates for PPI (e.g. glycogen synthase, glycogen phosphorylase, myosin light chain, phospholamban, ribosomal protein S6) have been identified (reviewed in [ 1, [10] [11] [12] ), whereas for other phosphoproteins (such as transcription factors) the contribution of PP I to their dephosphorylation remains to be further clarified.
Recent evidence from the study of cell cycle mutants has revealed that PPI also plays an important role in the regulation of mitosis. The temperature-sensitive Bim GlI mutant of Aspergillus nidulans carries a mutation in the PPlc gene. At the restrictive temperature, mutants are unable to complete anaphase successfully [55] . The fission yeast (SchizosaccharomY ces poinbe) gene dis2' also encodes a PP1c homologue, and mutations in this gene lead to a block in mitotic chromosome disjoining [17] . The dis2+ gene is identical to the bwvs + gene, which is involved in the initiation of mitosis in fission yeast [56] . Further, in budding yeast (SaccharomYces cerevisiae) the DIS2SI/GLC7 gene, which encodes a PPI catalytic subunit, is an essential gene. Recent experiments indicate that PP 1 plays a role in chromosome segregation [57] . This conclusion was reached through the study of the IPLI gene, which apparently encodes a protein kinase that is required for high-fidelity chromosome segregation. PP1 acts in opposition to the lpl kinase, since mis-segregation of chromosomes caused by a mutation in the kinase is partially suppressed by expression of a truncated DIS2SI/GLC7 gene. The data suggest that the truncated catalytic subunit is expressed and, although catalytically inactive, it is able to bind to regulatory subunits. As a consequence, overexpression of the truncated catalytic subunit competitively inhibits binding of the native catalytic subunit to its regulatory subunits. Interestingly, overexpression of the full-length gene in wild-type cells also results in chromosome mis-segregation.
Further evidence for a role of PP I in mitosis has been obtained from the study of Drosophila mutants [58, 59] . A mutation in the PPI 87B gene (one of four genes that encode PPI homologues) leads to flies that die at the larval-pupal boundary. Analysis of neuroblasts from such flies showed defective spindle organization, abnormal sister chromatid segregation, hyperploidy and excessive chromosome condensation, as well as a delay in progression through mitosis. That PP I is required for mitotic progression was confirmed by reintroduction of the PPI 87B gene, which resulted in normal mitosis.
Further evidence for a role for PPI during mitosis was demonstrated by microinjection experiments using rat fibroblasts [60] . Recently it was found that PPl is phosphorylated and inhibited by cdkl complexed with either cyclin A or B [61] .
Whether cdkl phosphorylates PPI in vivo remains to be established. Further work is necessary to define the role of PP1 during cell cycle progression.
PROTEIN PHOSPHATASE 2A Structure of PP2A Several trimeric holoenzyme forms of PP2A exist and have been extensively characterized. The core of these structures consists of a 36 kDa catalytic subunit (PP2Ac) complexed with a regulatory subunit of 65 kDa (PR65 or A subunit). As shown in Figure 2 , this core dimer associates with variable regulatory subunits of 55 kDa (PR55 or B subunit), 54 kDa (B' subunit), 72 kDa (PR72), 74 kDa (B" subunit) or 130 kDa (PR130) [62, 63] . In rilo, PP2A is probably only present as a trimer, but this remains a controversial issue because the core dimer has been purified from many different tissues. This suggests the possibility of subunit rearrangements where the variable subunits are able to associate and dissociate from the core dimer.
The exact function of the regulatory subunits is not yet completely resolved, but they probably influence substrate specificity and/or subcellular localization. It is noteworthy in this respect that PR72 contains a potential nuclear localization signal in its primary sequence [64] , possibly explaining the presence of PP2A in the nucleus [65] .
Molecular cloning revealed the existence of several isoforms of each subunit (reviewed in [58] Figure 3 Ceramide activates PP2A
Binding of tumour necrosis factor (TNF) to its receptor triggers a series of events (possibly involving phospholipase A2 activation) that leads to activation of sphingomyelinase and the formation of ceramide [72, 73] that in turn activates the trimeric PP2A.
PR55 (a, ,8, y) and two isoforms of PR72 exist [60] . Most PP2A subunits appear to be ubiquitously expressed. Interestingly, expression of PR55S, and y is mainly limited to neuronal tissues [62, 66] , whereas PR72 transcripts are only found in muscle tissue [64] . In Drosophila the situation is less complex, since every subunit cloned so far appears to be encoded by a single gene (see [62] ). In budding yeast (Saccharomyces cerevisiae) PP2A catalytic subunit is encoded by two genes (PPH21 and PPH22) [67, 68] . A related gene (PPH3) can provide some PP2A activity in the absence of PPH21 and PPH22. PP2A-deficient yeast is not viable, but can be rescued by PAMI1 overexpression [69] . PAMI has no homology to known protein phosphatases, but might activate a PP2A-like phosphatase. TPD3 and CDC55 genes (see below) encode the yeast homologues of PR65 and PR55 respectively [70, 71] .
Regulation of PP2A Activation by ceramide
The binding of tumour necrosis factor-a or y-interferon to their receptors leads to the activation of a sphingomyelinase, resulting in the formation of ceramide (see Figure 3) . The mechanisms that connect receptor activation to activation of sphingomyelinase are poorly understood (reviewed in [72] ). In vitro ceramide activates those trimeric forms of PP2A that contain either the PR55ax or the 54 kDa (B') variable regulatory subunit. In contrast, the PP2A dimer and the catalytic subunit are insensitive to ceramide [73] . The observations that dihydroceramide (which is physiologically inactive) is unable to activate the PP2A trimer and that okadaic acid can overcome the effects of ceramide on apoptosis and c-myc down-regulation suggest that PP2A is the most important mediator of ceramide action [72, 74] . The effect of ceramide on protein kinases might then be indirect [72] . For a recent review on this topic, see Kolesnick and Golde [75] .
Inhibition through phosphorylation of the catalytic subunit The catalytic subunit of PP2A can be phosphorylated in vitro by the tyrosine kinases p60V-$rc, pS6lck, epidermal growth factor receptor and insulin receptor [76] . Phosphorylation occurs on Tyr-307 at the C-terminus of the protein and leads to a 90%1" loss in activity; dephosphorylation reactivates the phosphatase. This reactivation is prevented by okadaic acid, suggesting an autodephosphorylation reaction.
Furthermore, serum stimulation or transformation of cells by p60v-src apparently promotes the transient phosphorylation of PP2A on Tyr, whereas serum starvation has the opposite effect [77] . The in vivo phosphorylation of the catalytic subunit has not been correlated with activity changes. Nevertheless, it has been suggested that activation of growth factor receptors leads to transient inactivation (Tyr phosphorylation) of PP2A, and thereby amplifies and prolongs activation of protein kinases [76] . This is an attractive model that places PP2A in a pivotal position to modulate signal transduction cascades. In support of this idea, Srinivasan and Begum [78] have recently shown that addition of insulin to rat skeletal muscle cells leads to a decrease in PP2A activity by 40-80 %. Furthermore, the fact that okadaic acid treatment of cells can lead to activation of some protein kinases points in the same direction [79] . Taken together the data suggest that the activity of PP2A can be modulated by extracellular signals and thereby can modulate signal transduction pathways.
In vitro phosphorylation of the catalytic subunit on threonine leading to a loss of activity has also been reported [80] . This reaction is catalysed by an autophosphorylation-activated protein kinase, and leads to about 80 % inactivation of PP2A [80] . This has the elegance of amplifying the signal propagated by the kinase. Strikingly, the kinase itself is dephosphorylated and inactivated by PP2A. Mechanistically these data are difficult to rationalize at the moment.
Carboxymethylation of the catalytic subunit Recently a carboxymethyltransferase, different from the known type II and type III methyltransferases, has been purified [81, 82] . The major substrate of this enzyme is a 36 kDa protein, subsequently identified as the catalytic subunit of PP2A. The purified methyltransferase catalyses methylation of the a-carboxyl group of the C-terminal Leu-309 residue of PP2Ac in vitro [82] . Methylation has moderate stimulatory effects on phosphatase activity and impairs binding of peptide-specific antibodies to the C-terminus of PP2Ac [83] . Strikingly, the C-terminal sequence of PP2Ac (Thr-Pro-Asp-Tyr-Phe-Leu) is conserved from yeast to man, suggesting that modifications of the C-terminus of PP2Ac may be a conserved regulatory mechanism [84] .
In Xenopus egg extracts, addition of cAMP increases methylation of PP2A, whereas okadaic acid inhibits methylation [85] . In view of the moderate effects of methylation on PP2A activity, it was suggested that this modification might influence the interaction of PP2Ac with its regulatory subunits [83] . C-terminal methylation of PP2Ac was also inhibited in titro by okadaic acid or microcystin [86] , suggesting that the inhibitory effect is mediated by binding to PP2Ac.
Tyrosine phosphatase activity of PP2A Although PP2A was originally purified as a Ser/Thr protein phosphatase it can, under certain conditions, dephosphorylate Tyr residues. The tyrosine phosphatase activity of PP2A towards exogenous substrates is increased in the presence of ATP or PP., tubulin and MAP-2 [87] . Furthermore, a 37 kDa protein (termed PTPA) was isolated and characterized which, in the presence of ATP and Mg2", activates the Tyr phosphatase activity of PP2A. This effect is limited to the dimeric form of PP2A, and to a lesser extent to the isolated catalytic subunit [88, 89] . The tyrosine phosphatase activity of PP2A after PTPA stimulation is of the same order of magnitude as its Ser/Thr (phosphorylase) phosphatase activity. The PTPA-induced tyrosine phosphatase activity of PP2A is stabilized by small-t or middle-T antigen [90] . Intriguingly, the mechanism whereby PTPA stimulates the tyrosine phosphatase activity of PP2A remains to be established.
Interaction with regulatory subunits The interaction of PP2Ac with the regulatory subunits PR65, PR55, PR72 and others influences its substrate specificity [91] [92] [93] . This is clear from studies with cdkl-phosphorylated substrates [91] . Dephosphorylation of a cdkl-phosphorylated histone Hi peptide occurs efficiently with PP2A trimers that contain either the PR55 or PR72 subunit, but not with the dimer or with PP2Ac. Furthermore, the presence of PR55, but not PR72, in the PP2A holoenzyme allows efficient dephosphorylation of a cdklphosphorylated retinoblastoma peptide. The observation is extended by the finding that 2 nM okadaic acid inhibits the dephosphorylation of cdkl -phosphorylated histone HI in diluted extracts from Xenopus eggs, human fibroblasts and rat liver [92] .
Further evidence that PP2A holoenzymes display different substrate specificities comes from the observation that the PP2A trimer containing PR72 preferentially dephosphorylates Ser-120 and Ser-123 in simian virus 40 (SV40) large-T antigen, whereas dephosphorylation of Thr-124 (the cdkl target site) is only efficiently catalysed by the PP2A trimer containing PR55 [93] .
Analysis of yeast and Drosophila mutants lacking one particular PP2A subunit confirmed the importance of the regulatory subunits. Yeast carrying a mutation in the TPD3 gene (encoding a PR65 homologue) shows defects in tRNA gene transcription and the cells become multinucleated [70] . Mutations in the CDC55 gene, encoding the homologue of PR55, lead to defects in cell septation and separation in yeast [71] and to abnormal anaphase resolution in the Drosophila aarl mutant [94] . The PP2A holoenzyme in brain extracts from aarl homozygous flies displays decreased activity towards the cdkl-phosphorylated substrates histone H1 and caldesmon, whereas activity towards other substrates is not affected [95] .
The Drosophila wins' mutant carries a P-element insertion in the same gene as the aarl mutant but is a stronger allele [95, 96] . The [96] . From this study it can be concluded that the PP2A containing the PR55 Interaction with tumour antigens SV40 and polyoma small-t and polyoma middle-T antigens form complexes with the PR65/PP2Ac dimer, probably by displacing the variable third subunit (reviewed in [67, 97] ). This exchange of a regulatory subunit for a tumour antigen has a certain degree of specificity, as small-t antigen is able to exchange with the PR55 subunit but not with the 54 kDa (B') subunit [98] . The interaction of PP2A with tumour antigens has an inhibitory effect on the dephosphorylation of in Nitro substrates such as myosin light chain, myelin basic protein, large-T antigen and p53 [97] .
When analysed in cells the interaction of small-t with PP2A results in inhibition of PP2A-mediated dephosphorylation of MEK (ERK kinase) and ERK (extracellular signal regulated kinase; also termed MAP kinase) and thus in receptor-independent activation of these two kinases. This leads to cell proliferation without affecting Raf kinase activity [98] .
Physiological role of PP2A
Through the use of okadaic acid and related inhibitors it is possible to specifically inhibit PP2A activity in cell-free extracts. Although one cannot exclude the possibility that PP2A-like enzymes are affected, this approach, often in combination with purified PP2A preparations, has been used to identify potential PP2A substrates in a wide variety of cellular processes (reviewed in [1, 11, 63, 97] ), such as metabolism, muscle contraction, synaptic transmission, signal transduction, RNA splicing and cell cycle progression.
Cell cycle regulation Progression of eukaryotic cells through the cell division cycle is primarily controlled by the activity of the cyclin-dependent protein kinases. The best studied event is the transition from G2 to M phase, which is controlled by cdkl (also referred to as cdc2 or p34) complexed with cyclin B (reviewed in [99] Phosphorylation of cdkl on Thr-1 61 is absolutely required for activity, whereas phosphorylation of Thr-1 5 and Tyr-14 is inhibitory. Phosphorylation of Thr-1 61 is catalysed by CAK, and the pathway leading to Thr-161 phosphorylation is inhibited by PP2A. Thr-161 is not a direct PP2A substrate [99, 102] . cdkl activation requires dephosphorylation of Thr-15 and Tyr-14 by cdc25. cdc25 is only active in the phosphorylated form and is kept inactive by PP2A [104] .
CAK, however, does not vary between interphase and mitosis [103] ; thus the significance of the hypothetical PP2A-mediated dephosphorylation of CAK is not immediately obvious. Moreover, PP2A dephosphorylates cdc25, keeping it in a low-activity state [104] . This also contributes to the negative effect of PP2A on the G2 to M transition.
PP2A and transcription factors
Phosphorylation of transcription factors is a major mechanism utilized to control their intracellular location, trans-activating potential or DNA-binding properties (reviewed in [105] ). Although progress has been made in identifying the kinases responsible for these phosphorylations, much less is known about the phosphatases that act upon transcription factors. The best studied case is that of the transcription factor CREB, which binds to the cAMP-responsive element. CREB is phosphorylated on Ser-133, and this phosphorylation increases its trans-activation activity without affecting its DNA-binding properties. An initial study using isolated phosphatase catalytic subunits suggested that PPI was the major CREB phosphatase [106] , whereas a later study showed that CREB dephosphorylation in nuclear extracts is catalysed by a specific holoenzyme of PP2A [107] . Furthermore, the presence of smallt antigen inhibits CREB dephosphorylation both in vitro and in intact cells [108] . Microinjection of an expression vector that encodes a constitutively active form of 1-1, however, leads to an increase in the phosphorylation state of CREB, again indicating a role for PPl in CREB dephosphorylation [109] .
One explanation for the discrepancy between these studies might be the use of different cell types (PC 12 Regulation of PP2B PP2B is dependent upon Ca`+ for activity and is stimulated by calmodulin, but the purified enzyme also requires bivalent metal ions such as Mn2+, Mg2+ or Ni2+ (reviewed in [110] ). Interestingly, calcineurin becomes activated at much lower Ca2+ concentrations (Kd = 0.1 nM) than the Ca2+/calmodulin-dependent protein kinase 11 (K,, = 45 nM).
Partial proteolysis of calcineurin converts it to a form which no longer requires Ca2+ for activity. This is due to destruction of the C-terminus of the catalytic subunit, which contains an autoinhibitory domain [114] . Binding of calmodulin to a nearby site and binding of Ca2`to the B-subunit allows the enzyme to overcome this auto-inhibition.
Inhibition of calcineurin activity towards model substrate peptides by the immunosuppressant/immunophilin complex (FK506/FKBP or cyclosporin A/cyclophilin) is mediated by both calcineurin subunits [115] . Association of calcineurin with FK506/FKBP is dependent on Ca2+, unless the auto-inhibitory domain on the catalytic subunit is removed [115] . More recent studies [116, 117] indicate that both the FK506/FKBP and cyclosporin A/cyclophilin interact with the latch region of the CNB subunit but that the association of CNB with CNA is required for the former to adopt the correct conformation to permit interaction with drug/immunophilin complexes. Interestingly, the so-called latch region allosterically activates the CNA catalytic subunit.
PP2B has a rather restricted substrate specificity. The ox subunit of phosphorylase kinase, 1-1, DARPP-32 and the type I1 regulatory subunit of cAMP-PK (RII) are excellent in tlitro substrates.
Physiological role of PP2B PP2B and T-cell activation T-cell activation, in response to the interaction of the T-cell receptor with antigen, is mediated by induction of interleukin-2 gene expression. Activation of at least two signalling pathways is needed for this induction (reviewed in [118] ). One pathway can be activated with Ca2+ ionophores, and the other with phorbol esters. At the level of the promoter, induction of interleukin-2 gene expression requires co-operative interactions of several transcription factors.
The Ca2+-dependent pathway is mediated via activation of calcineurin. This leads to dephosphorylation of the cytosolic subunit of the transcription factor NF-AT, as is shown in Figure   5 . The dephosphorylated subunit then migrates to the nucleus where it combines with nuclear factors (probably jun and fos) to form the transcription factor NF-AT [119] . NF-AT binds to, and activates, the interleukin-2 promoter. Calcineurin also appears to mediate effects on other Ca2+-sensitive elements within the interleukin-2 promoter (see Figure  5) , such as the binding sites for Oct-I and NF-KB. Surprisingly, the effect of calcineurin on NF-KB is mediated by phosphorylation (inactivation) of IKB, the cytosolic inhibitor of NF-KB. As depicted in Figure 5 , this might be due to calcineurinmediated activation of an IKB kinase [120] .
The immunosuppressants FK506 and cyclosporin A block the activation of T-cells by inhibiting calcineurin. Although FK506 and cyclosporin A are not inhibitory to calcineurin as such, they become potent inhibitors when complexed to their intracellular receptors FKBP and cyclophilin respectively [121] .
PP2B in other systems
The finding that PP2B is specifically inhibited by FK506/FKBP and cyclosporin A/cyclophilin complexes made it possible to investigate the function of PP2B in a variety of cellular systems. In these experiments a control is provided by the overexpression of PP2B (which overcomes the effects of immunosuppressants), or by the use of antagonists such as rapamycin, which binds to FKBP without affecting PP2B. Using this approach, Schwaninger et al. [122] showed that, in a pancreatic acinar cell line, calcineurin was responsible for mediating Ca2+-induced gene expression, driven by the cAMP-responsive element. In isolated pancreatic acini, a role for PP2B in the release of amylase in response to cholecystokinin and Ca2+-mobilizing agents was suggested [123, 124] .
Inhibition of PP2B results in stimulation of corticotropin secretion in a rat pituitary tumour cell line [125] , and protects thymocytes and immature B-cells against Ca2+-induced apoptosis [126, 127] . Furthermore, PP2B mediates the a-adrenergic stimulation of Na+/K+-ATPase in renal tubule cells [128] and regulates K+ channels in guard cells from the plant Vicia faba [129] .
FK506 protects primary cortical cultures against N-methyl-Daspartate (NMDA) neurotoxicity [130] , and PP2B functions in a negative feedback mechanism regulating the channel opening of the NMDA subtype of the glutamate receptor [131] . Calcineurin was shown to mediate the effect of activation of the NMDA receptor in the hippocampus [132] and the striatum [133] .
In most of these studies, however, the direct substrates of calcineurin were not determined. It appears that activation of calcineurin in response to Ca'+ is an early event. This is reflected by the model substrates of PP2B (1-1, RII, DARPP-32), which themselves are mostly inhibitors of protein phosphatases and protein kinases. It appears likely that calcineurin functions in a cascade system [1] and is the key enzyme controlling the activity state of other enzymes with a much broader substrate specificity. This view is confirmed by the study of calcineurin function in NMDA receptor signalling [123, 124] , where calcineurin activation leads to dephosphorylation (inactivation) of 1-1 /DARPP- 32 and thus indirectly to PPl activation.
The budding yeast SaccharoniYces cererisiae turns out to be a good model system for the study of PP2B function. In this organism, PP2B is encoded by two genes (CMPI and CMP'). A double mutant lacking both genes was isolated that grows normally under standard conditions [134] . High NaCl concentrations, howevr, inhibit growth of this double mutant, indicating that PP2B is responsible for the stimulation of Nat export [135] . The same phenotype was observed in a mutant lacking a functional B subunit of calcineurin [136] . The authors suggested T-cell activation is triggered in part by activation of calcineurin, which directly or indirectly leads to dephosphorylation of NF-ATc. Dephosphorylated NF-ATc migrates to the nucleus where it assembles with other subunits into the transcription factor NF-AT, leading to interleukin-2 gene expression [118] [119] [120] [121] . Activated calcineurin inactivates IKB, possibly by activating an IKB kinase [120] . Phosphorylated IKB dissociates from NF-KB, which then also migrates to the nucleus and binds to the interleukin-2 promoter. The FK506/FKBP complex blocks these events by inhibiting calcineurin [121] .
that this mutated B subunit could act as a dominant negative. They further showed that the phenotype was due to reduced expression of ENA1, a gene encoding a P-type ATPase involved in Li' and Na+ efflux. Again PP2B seems to act indirectly, in this case by controlling gene expression. In Schizosaccharomyces pombe, PP2B is encoded by a single gene, termed ppbJ+ [137] . Disruption of this gene leads to defects in cytokinesis and to virtually sterile cells. In agreement with this, defects in cytokinesis were also observed following treatment of fission yeast with cyclosporin A.
PROTEIN PHOSPHATASE 2C
PP2C was originally identified as a Mg2+-dependent protein phosphatase (half-maximal activity at 1 mM Mg2+). The enzyme is monomeric with a molecular mass of 43-48 kDa (reviewed in [1] ). Two major isoforms (a, ,B) of PP2C have been cloned. Further analysis revealed the existence of subtypes for both isoforms. Three ac subtypes have been identified, with al being the most dominant species. Two subtypes of the isoform appear to be the result of alternative splicing, since they differ only at their C-terminus. Whereas /51 is ubiquitously expressed, /12 transcripts are only found in brain and heart [138, 139] . The latter observation might be important, since PP2C was suggested to play a role in Ca2+-dependent signal transduction in brain.
More specifically, PP2C might catalyse the dephosphorylation of autophosphorylated Ca2+/calmodulin-dependent protein kinase II in granule cells of the cerebellum [140] .
Interestingly, Peruski et al. [139] identified a region of sequence identity between PP2C and PP1/PP2A/PP2B that is located in the putative catalytic domain and spans 80 amino acid residues. This suggests, as pointed out by these authors, that all of these enzymes are derived from a common ancestor.
In both Saccharomyces cerevisiae and Schizosaccharomyces pombe three genes encoding PP2C homologues have been identified [141] [142] [143] . The analysis of yeast strains carrying deletions of these three genes suggests the existence of a fourth isoform [143] . Mutations in the TPDI/PTCJ gene of Saccharomyces cerevisiae [142, 144] cause a temperature-sensitive growth defect (failure of cell separation during mitosis) and are accompanied by the accumulation of unspliced tRNA species. In Schizosaccharomyces pombe, the PP2C isoform, encoded by the ptcl+ gene, is important in the heat shock response. mRNA levels ofptclJ+ increase 5-1 0-fold upon heat shock, and deletion mutants have greatly reduced ability to survive heat shock [145] .
Recent analysis of both yeast strains has provided clues on the in vivo targets of PP2C [142, 143] . The results from both of these studies implicate PP2C in signal transduction processes involved in osmoregulation. It appears that PP2C negatively regulates an osmosensing MAP kinase cascade comprising the PBS2 and In Arabidopsis thaliana the abil gene, essential for the response to the plant hormone abscisic acid, was shown to encode a protein homologous to PP2C. Interestingly, this PP2C homologue has a putative Ca2l-binding site [146, 147] .
OTHER PROTEIN PHOSPHATASES
Many novel protein phosphatases have been recently identified by molecular cloning. These are summarized in Table 1 and discussed below.
Protein phosphatase A
The N-terminal halves of the proteins encoded by orf221 of bacteriophage and the homologous gene of 7T80 show 35 %o identity to PP1 and PP2A repectively [148] . Escherichia coli infected with AgtlO contains a casein phosphatase activity which is absent from uninfected cells or from cells infected with Agtl 1, lacking part of orf221 [149] . More recently, the orf221 gene was cloned and expressed in bacteria, and the recombinant protein was purified and shown to posses Ser/Thr phosphatase activity. Characterization of the enzyme revealed that it was resistant to okadaic acid, 1-1 and 1-2, but absolutely required Mn2+ for activity [150] .
Mitochondrial protein phosphatases
Labelling of mitochondria with radioactive phosphate results in the detection of two major phosphoproteins: pyruvate dehydrogenase and branched-chain 2-oxo-acid dehydrogenase (reviewed in [151] ). Dephosphorylation of these proteins appears to be catalysed by highly specific phosphatases. The phosphatase acting upon pyruvate dehydrogenase consists of a 97 kDa flavoprotein and a catalytic subunit of about 50 kDa [151] . The latter has been cloned and expressed in bacteria. The activity of the recombinant protein towards pyruvate dehydrogenase was Mg2+-dependent and Ca2+-stimulated [152] . Some identity with the primary sequence of PP2C is observed, suggesting a common origin of the two phosphatases.
Protein phosphatase Z The Saccharomnces cerevisiae enzyme PPZ exists in two isoforms (PPZ1 and PPZ2) that show about 60 0 identity to yeast PP1 and 4000 identity to PP2A [153, 154] . Characteristic of these phosphatases is a large Ser-rich N-terminal extension. Both isoforms of PPZ are involved in the maintenance of osmotic stability in yeast [155, 156] Protein phosphatase SIT-4 SIT-4 was identified as a suppressor of a mutation that leads to defects in the transcription of the HIS4 gene in Saccharomyces cerevisiae [161] . Later SIT-4, a PP2A-like protein phosphatase, was shown to play a role in glycogen metabolism. SIT-4 mutants show much higher levels of glycogen phosphorylase a and have a much lower glycogen synthase activity ratio compared with wild-type cells [162] . Furthermore SIT-4 is important for the GI [170] . It is predicted that the mammalian genome encodes 1000 protein phosphatases (including both Ser/Thr and Tyr phosphatases). If many of these new species are as complex as PP1/PP2A in terms of regulatory subunits then the total number of phosphatase holoenzymes is likely to be higher than this figure. We are therefore approaching a situation where there is one phosphatase for every kinase. This may not be the beginning of the end, but certainly it is the end of the beginning (with apologies to W. Churchill!). Until recently, protein phosphatases were perceived as rather unsophisticated components in the cellular tapestry of phosphorylation/dephosphorylation reactions. It was also thought that there are only a few relatively unspecific phosphatases capable of resetting the work of numerous protein kinases. It is now apparent that both of these ideas were oversimplistic. What should also be appreciated is that the mechanisms of regulation of the Ser/Thr protein phosphatases will be as complex and varied as the enzymes themselves.
The picture that appears to be emerging is either that the regulation of phosphatases is mediated by the assembly of complex holoenzymes consisting of catalytic and regulatory subunits, or that the catalytic subunits are fused regulatory domains. Both of these types of regulation are very reminiscent of those adopted by the protein kinase superfamily.
Apart from identifying other members of the protein phosphatase family, the challenge in the future will be to understand how the different regulatory subunits function in terms of responding to the appropriate signals to bring about the orderly dephosphorylation of target proteins and enzymes. The example of the PR55 mutant from Drosophila is particularly illustrating in this respect. In this case the loss of a single regulatory subunit leads to a dramatic phenotype, i.e. neuroblasts fail to complete the metaphase/anaphase transition. This result suggests that a subset of substrates is not regulated (dephosphorylated?) correctly, and that the PR55 subunit is crucial in identifying these proteins.
Identification of substrates is likely to be an important aspect of future studies. This could also involve finding the appropriate kinase to phosphorylate a specific substrate. The use of the twohybrid system will undoubtedly help in this identification process.
Another exciting problem with respect to the oligomeric phosphatases is how the cell regulates the assembly of the different subunits into the correct holoenzyme of a particular cell type or tissue. Part of this control may be at the transcriptional level, e.g. binding sites for brain-specific transcription factors in the promoter of the PR55/? and PR55y genes. It seems likely, however, that translational and post-translational control mechanisms also contribute to this regulation.
Overall it can be stated that our vision of the protein phosphatase field has been greatly enhanced through the use of molecular genetic techniques, but there is still some way to go. We are indeed in a new era for this group of enzymes.
